Previous Close | 142.06 |
Open | 143.24 |
Bid | 132.00 x 1000 |
Ask | 148.32 x 800 |
Day's Range | 133.54 - 143.24 |
52 Week Range | 29.56 - 214.07 |
Volume | 411,153 |
Avg. Volume | 1,033,108 |
Market Cap | 6.579B |
Beta (5Y Monthly) | 0.70 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.76 |
Earnings Date | Feb 04, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 146.00 |
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has exercised its right of first refusal to expand the lease for its "Factory of the Future" manufacturing facility near Portland, Oregon.
Everyone knows that ARK Invest CEO Cathie Wood is a huge fan of Tesla (NASDAQ: TSLA). In this Motley Fool Live video recorded on April 7, Motley Fool contributors Keith Speights and Brian Orelli identify four healthcare stocks that are among Wood's top holdings that just might deliver bigger gains than Tesla.
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a partnership with Pure Biologics to accelerate the discovery of immuno-oncology antibody-based drugs.